Claims assessment · Product claim
Bioplastic” / “bio-based plastic
Typical treatment across five regimes. Every verdict below is tied to a stated legal hook.
Market comparison
How this claim is typically treated
Five major markets · one reviewed comparison
| Market | Typical treatment | Legal basis | What is required |
|---|---|---|---|
| European UnionEU | Conditional | View legal reasoningUCPD; SUPD context; EU policy framework on bioplastics | Bio-based ≠ biodegradable — claims must not conflate; certified bio-based content share (EN 16785) and end-of-life route disclosed. |
| United KingdomUK | Conditional | View legal reasoningCMA Code; ASA | Separate bio-content from biodegradability claims explicitly. |
| United StatesUS | Conditional | View legal reasoningFTC 260.8/.12; USDA BioPreferred | Bio-based content % per ASTM D6866; no implied degradability. |
| CanadaCA | Conditional | View legal reasoningCompetition Act s.74.01(1)(b.1) | Content testing; end-of-life evidence separate. |
| AustraliaAU | Conditional | The cited source is recorded in the assessment. View legal reasoningACL s.18 | Content % verified; disposal-route clarity. |